Author

B. S. Knudsen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Qian· 2 shared M. R. Freeman· 2 shared R. Murali· 2 shared S. You· 2 shared W. Yang· 2 shared Y. Yan· 2 shared A. Chatterjee· 1 shared A. Gertych· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Qian

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer

C. Qian, Q. Yang, M. Rotinen, R. Huang, h. Kim, B. Gallent, Y. Yan, R. M. Cadaneanu, B. Zhang, S. Kaochar, S. J. Freedland, E. M. Posadas, L. Ellis, D. Di Vizio, C. Morrissey, , M. R. Freeman

This study identifies ONECUT2 as a master transcription factor that drives resistance in prostate cancer through multiple mechanisms, including activation of neuroendocrine and adenocarcinoma variants, and shows that its inhibition can suppress treatment-resistant lineage plasticity.

bioRxiv · Sep 28, 2023 · PreprintCancer Biology

RIPK2 Stabilizes c-Myc and is an Actionable Target for Inhibiting Prostate Cancer Metastasis

Y. Yan, B. Zhou, C. Qian, A. Vasquez, A. Chatterjee, X. Yuan, E. Posadas, N. Kyprianou, B. S. Knudsen, R. Murali, A. Gertych, S. You, M. R. Freeman, W. Yang

This study identifies RIPK2 as a target for inhibiting prostate cancer metastasis by stabilizing c-Myc and shows its suppression reduces disease progression.

bioRxiv · May 14, 2020Cancer Biology